Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04FQZ
|
|||
Former ID |
DNC007840
|
|||
Drug Name |
4-(4-hexylphenyl)-4-oxobut-2-enoic acid
|
|||
Synonyms |
CHEMBL237601; SCHEMBL16227167
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H20O3
|
|||
Canonical SMILES |
CCCCCCC1=CC=C(C=C1)C(=O)C=CC(=O)O
|
|||
InChI |
1S/C16H20O3/c1-2-3-4-5-6-13-7-9-14(10-8-13)15(17)11-12-16(18)19/h7-12H,2-6H2,1H3,(H,18,19)
|
|||
InChIKey |
HKEVTQICMJNUNY-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Thyroid hormone receptor alpha (THRA) | Target Info | Inhibitor | [1] |
Thyroid hormone receptor beta (THRB) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Thyroid hormone signaling pathway | ||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | Endochondral Ossification | |||
Nuclear Receptors | ||||
SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.